Announcement of members of the first order audit
committee of the Company.
Date of events
2022/07/05
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/07/05
2.Name of the functional committees:Audit committee
3.Name of the previous position holder:Not applicable.
4.Resume of the previous position holder:Not applicable.
5.Name of the new position holder:
Independent Director:Zeng,Hui-Jin
Independent Director:Liu,Mei-An
Independent Director:Chen,Rui-Xin
6.Resume of the new position holder:
Independent Director:Zeng,Hui-Jin/Partner, Deputy Director, Chief Operating
Officer, Chief Strategy Officer of PricewaterhouseCoopers Taiwan.
Independent Director:Liu,Mei-An/Deputy General Manager of FUBON FINANCIAL
HOLDING VENTURE CAPITAL CORPORATION.
Independent Director:Chen,Rui-Xin/Former Deputy Director at the Trademark
Division, Bureau of Standards, Metrology and Inspection, MOEA.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):new appointment
8.Reason for the change:new appointment
9.Original term (from __________ to __________):Not applicable.
10.Effective date of the new member:2022/07/05
11.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bionime Corporation published this content on 05 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2022 09:42:03 UTC.
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
BIONIME CORPORATION 
